Which has the lower trailing P/E, GMED or MOH?

GMED has the lower trailing P/E: GMED trades at 21.22 and MOH at 1065.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or MOH?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus MOH at 13.56%.

Is GMED or MOH more profitable?

GMED runs the higher net margin — GMED at 17.03% versus MOH at -0.02%.

How have GMED and MOH total returns compared?

Over the past 10 years, GMED delivered 13.76% and MOH delivered 14.10% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Molina Healthcare, Inc. (MOH)

A side-by-side comparison of Globus Medical, Inc. and Molina Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$11.13B

$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

MOH

Molina Healthcare, Inc.

$10.37B

$198.75HealthcareDelayed quote: Aug 27, 2026, 4:02 PM EDT

Total return — GMED vs MOH

growth of $100 · dividends reinvested · last 10y

GMED +274.5% (+14.1%/yr)MOH +273.9% (+14.1%/yr)GMED compounded faster over this window

GMED MOH

GMED vs MOH: by the numbers

•GMED is the larger company ($11.13B vs $10.37B market cap).
•GMED trades at the lower trailing earnings multiple (21.22 vs 1065.42 P/E), one valuation lens rather than an overall verdict.
•GMED is profitable (17.03% net margin) while MOH runs a net loss (-0.02%).
•GMED grew revenue faster over the past five years (27.65% vs 13.56% CAGR).

Metrics side by side

Valuation

Metric	GMED	MOH
P/E ratio	21.22	1065.42
Forward P/E	16.57	N/A
P/S ratio	3.63	0.23
P/B ratio	2.39	2.49
EV / EBITDA	11.79	20.16
FCF yield	6.58%	2.61%

Profitability

Metric	GMED	MOH
Gross margin	68.55%	13.07%
Operating margin	20.75%	0.66%
Net margin	17.03%	-0.02%
ROE	11.23%	-0.17%
ROIC	10.49%	3.56%

Growth (annualized)

Metric	GMED	MOH
Revenue CAGR (5Y)	27.65%	13.56%
EPS CAGR (5Y)	30.79%	-4.78%
FCF CAGR (5Y)	29.93%	-33.88%
Total return CAGR (5Y)	0.22%	-5.18%

Frequently asked

Which has the lower trailing P/E, GMED or MOH?: GMED has the lower trailing P/E: GMED trades at 21.22 and MOH at 1065.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or MOH?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus MOH at 13.56%.
Is GMED or MOH more profitable?: GMED runs the higher net margin — GMED at 17.03% versus MOH at -0.02%.
How have GMED and MOH total returns compared?: Over the past 10 years, GMED delivered 13.76% and MOH delivered 14.10% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full MOH analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Molina Healthcare P/E ratio Globus Medical ROE Molina Healthcare ROE Globus Medical operating margin Molina Healthcare operating margin Globus Medical revenue growth Molina Healthcare revenue growth Globus Medical free cash flow Molina Healthcare free cash flow

Globus Medical & Molina Healthcare appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.